SSTR2 and cancer: Our results showed that SSTR2 promoter methylation levels in cancer tissues were significantly higher than in the paired non-tumor tissues (Figure 3a, 5.80 ± 3.87 % versus 3.67 ± 3.22 %, P = 0.001, adjusted P = 0.003).